Source: Rheumatology. Unidade: FM
Subjects: COVID-19, DOENÇAS AUTOIMUNES, VACINAÇÃO, EVENTO ADVERSO A MEDICAMENTO
ABNT
DEY, Mrinalini et al. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology, v. 62, n. 5, p. E147-E152, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53815. Acesso em: 31 ago. 2024.APA
Dey, M., Naveen, R., Nikiphorou, E., Sen, P., Saha, S., Lilleker, J. B., et al. (2023). Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology, 62( 5), E147-E152. doi:10.1093/rheumatology/keac603NLM
Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, Kardes S, Day J, Milchert M, Shinjo SK. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study [Internet]. Rheumatology. 2023 ; 62( 5): E147-E152.[citado 2024 ago. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53815Vancouver
Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, Kardes S, Day J, Milchert M, Shinjo SK. Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study [Internet]. Rheumatology. 2023 ; 62( 5): E147-E152.[citado 2024 ago. 31 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53815